AI radiology screening and interpretation
Uses AI to support earlier cancer detection in breast imaging and chest X-ray interpretation, with products tailored to 2D mammography, 3D DBT, and CXR workflows.
Lunit medical AI software for cancer screening and precision oncology helps radiology and oncology teams analyze imaging and tissue data for earlier detection and biomarker research.
Lunit is a medical AI software company focused on cancer detection and precision oncology. Its platform turns imaging and pathology data into clinical intelligence for screening, diagnosis support, biomarker research, treatment strategy development, and drug development.
The site presents two main product areas: AI radiology software for earlier cancer detection and AI precision oncology software for biomarker discovery, IHC analysis, and companion diagnostics development. Lunit also describes a connected ecosystem that is built to fit into real-world workflows and scale across institutions and research partners.
Uses AI to support earlier cancer detection in breast imaging and chest X-ray interpretation, with products tailored to 2D mammography, 3D DBT, and CXR workflows.
Provides breast imaging tools such as risk pathways, analytics scorecards, patient communication, and image-quality feedback to support screening programs.
Detects 11 major thoracic abnormalities, supports tuberculosis screening, flags normal chest X-ray cases, and surfaces critical results to help prioritize reads.
Applies digital pathology AI to biomarker discovery, IHC quantification, immune phenotyping, and genotype prediction for precision oncology research.
Supports biomarker strategy and CDx development with tissue-based AI outputs aimed at translational research and clinical trial efficiency.
Describes a modular platform with interoperable solutions, broad scanner and file type compatibility, and scalable deployment across digital pathology platforms and CRO partners.
Supports screening programs that want AI assistance for 2D mammography, 3D tomosynthesis, risk assessment, and patient follow-up workflows.
Helps radiology teams interpret chest X-rays by detecting abnormalities, surfacing critical findings, and flagging normal cases to reduce workload.
Gives oncology and translational research teams AI-based analysis for immune phenotyping, IHC quantification, and genotype prediction from tissue samples.
Supports biopharma groups that need biomarker strategies and companion diagnostics development for oncology programs.
Lunit’s radiology products support breast imaging and chest X-ray workflows. The precision oncology products support biomarker discovery, IHC analysis, genotype prediction, and companion diagnostics development.
Yes. The site describes Lunit as a modular platform with interoperable solutions that can integrate into real-world workflows, and it also mentions broad scanner and file type compatibility for the precision oncology suite.
For precision oncology, the source states that Lunit SCOPE products are for research use only and not for use in diagnostic procedures or decisions. The radiology pages describe clinical use for screening and interpretation workflows.
The pricing page at `lunit.io/pricing` returns a page-not-found result, so the source does not provide public pricing information.
The site points readers to contact a specialist, schedule a demo, or contact sales for more information, detailed validation results, or deployment questions.